269 related articles for article (PubMed ID: 16621031)
1. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions.
Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P
Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031
[TBL] [Abstract][Full Text] [Related]
2. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
3. Heat-stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function.
Hubbe M; Altevogt P
Eur J Immunol; 1994 Mar; 24(3):731-7. PubMed ID: 8125140
[TBL] [Abstract][Full Text] [Related]
4. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
[TBL] [Abstract][Full Text] [Related]
5. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen.
Liu Y; Jones B; Brady W; Janeway CA; Linsley PS
Eur J Immunol; 1992 Nov; 22(11):2855-9. PubMed ID: 1385153
[TBL] [Abstract][Full Text] [Related]
6. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein.
Blanco B; Holliger P; Alvarez-Vallina L
Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444
[TBL] [Abstract][Full Text] [Related]
7. Induction of B cell costimulatory function by recombinant murine CD40 ligand.
Kennedy MK; Mohler KM; Shanebeck KD; Baum PR; Picha KS; Otten-Evans CA; Janeway CA; Grabstein KH
Eur J Immunol; 1994 Jan; 24(1):116-23. PubMed ID: 7517359
[TBL] [Abstract][Full Text] [Related]
8. MRC OX-2 defines a novel T cell costimulatory pathway.
Borriello F; Lederer J; Scott S; Sharpe AH
J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
[TBL] [Abstract][Full Text] [Related]
9. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA
Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017
[TBL] [Abstract][Full Text] [Related]
10. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
[TBL] [Abstract][Full Text] [Related]
11. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation.
Inobe M; Aoki N; Linsley PS; Ledbetter JA; Abe R; Murakami M; Uede T
J Immunol; 1996 Jul; 157(2):582-8. PubMed ID: 8752905
[TBL] [Abstract][Full Text] [Related]
12. A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway.
Challita-Eid PM; Penichet ML; Shin SU; Poles T; Mosammaparast N; Mahmood K; Slamon DJ; Morrison SL; Rosenblatt JD
J Immunol; 1998 Apr; 160(7):3419-26. PubMed ID: 9531302
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of glycolipid-anchored B7-1 (CD80) from baculovirus-infected insect cells: protein transfer onto tumor cells.
Nagarajan S; Selvaraj P
Protein Expr Purif; 1999 Nov; 17(2):273-81. PubMed ID: 10545276
[TBL] [Abstract][Full Text] [Related]
14. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
[TBL] [Abstract][Full Text] [Related]
15. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy.
McHugh RS; Nagarajan S; Wang YC; Sell KW; Selvaraj P
Cancer Res; 1999 May; 59(10):2433-7. PubMed ID: 10344754
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation.
Doty RT; Clark EA
J Immunol; 1996 Oct; 157(8):3270-9. PubMed ID: 8871621
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
Holliger P; Manzke O; Span M; Hawkins R; Fleischmann B; Qinghua L; Wolf J; Diehl V; Cochet O; Winter G; Bohlen H
Cancer Res; 1999 Jun; 59(12):2909-16. PubMed ID: 10383154
[TBL] [Abstract][Full Text] [Related]
18. A triad of costimulatory molecules synergize to amplify T-cell activation.
Hodge JW; Sabzevari H; Yafal AG; Gritz L; Lorenz MG; Schlom J
Cancer Res; 1999 Nov; 59(22):5800-7. PubMed ID: 10582702
[TBL] [Abstract][Full Text] [Related]
19. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.
Lenschow DJ; Sperling AI; Cooke MP; Freeman G; Rhee L; Decker DC; Gray G; Nadler LM; Goodnow CC; Bluestone JA
J Immunol; 1994 Sep; 153(5):1990-7. PubMed ID: 7519638
[TBL] [Abstract][Full Text] [Related]
20. T-cell co-stimulation through B7RP-1 and ICOS.
Yoshinaga SK; Whoriskey JS; Khare SD; Sarmiento U; Guo J; Horan T; Shih G; Zhang M; Coccia MA; Kohno T; Tafuri-Bladt A; Brankow D; Campbell P; Chang D; Chiu L; Dai T; Duncan G; Elliott GS; Hui A; McCabe SM; Scully S; Shahinian A; Shaklee CL; Van G; Mak TW; Senaldi G
Nature; 1999 Dec; 402(6763):827-32. PubMed ID: 10617205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
